Chemoinformaics analysis of (9S,10E,12Z,15Z)-9-HYDROXY-10,12,15-OCTADECATRIENOIC-ACID
Molecular Weight | 294.435 | nRot | 13 |
Heavy Atom Molecular Weight | 264.195 | nRig | 4 |
Exact Molecular Weight | 294.219 | nRing | 0 |
Solubility: LogS | -3.48 | nHRing | 0 |
Solubility: LogP | 4.398 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 52.4698 |
nHD | 2 | BPOL | 30.9642 |
QED | 0.296 |
Synth | 3.165 |
Natural Product Likeliness | 1.937 |
NR-PPAR-gamma | 0.938 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.01 |
HIA | 0.071 |
CACO-2 | -4.739 |
MDCK | 0.0000207 |
BBB | 0.604 |
PPB | 0.968459 |
VDSS | 0.545 |
FU | 0.0230624 |
CYP1A2-inh | 0.046 |
CYP1A2-sub | 0.205 |
CYP2c19-inh | 0.017 |
CYP2c19-sub | 0.324 |
CYP2c9-inh | 0.036 |
CYP2c9-sub | 0.986 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.255 |
CYP3a4-inh | 0.039 |
CYP3a4-sub | 0.042 |
CL | 4.266 |
T12 | 0.87 |
hERG | 0.025 |
Ames | 0.034 |
ROA | 0.371 |
SkinSen | 0.968 |
Carcinogencity | 0.627 |
EI | 0.566 |
Respiratory | 0.953 |
NR-Aromatase | 0.182 |
Antiviral | Yes |
Prediction | 0.547253 |